Imbalanced effector and regulatory cytokine responses may underlie mycobacterial immune restoration disease

QR Code

Imbalanced effector and regulatory cytokine responses may underlie mycobacterial immune restoration disease

Background: Immune restoration disease (IRD) is an adverse consequence of antiretroviral therapy, where the restored pathogen-specific response causes immunopathology. Mycobacteria are the pathogens that most frequently provoke IRD and mycobacterial IRD is a common cause of morbidity in HIV-infected...

Full description

Bibliographic Details
Main Authors:	Lim, A., D'Orsogna, L., Price, Patricia, French, M.
Format:	Journal Article
Published:	2008
Online Access:	http://hdl.handle.net/20.500.11937/29786

Similar Items

TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease
by: Tan, D., et al.
Published: (2011)

Mycobacterial immune restoration disease: One symphony, two or many?
by: Price, Patricia
Published: (2012)

Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis
by: Tan, D., et al.
Published: (2008)

Mycobacterial antibody levels and immune restoration disease in HIV patients treated in South East Asia
by: Sumatoh, H., et al.
Published: (2011)

Immune restoration disease complicating antiretroviral therapy in patients with HIV infection: Implications and solutions
by: French, M., et al.
Published: (2008)

Increased plasma CXCL10 may be a marker of increased risk of immune restoration disease associated with nonviral pathogens
by: Oliver, B., et al.
Published: (2012)

Immune restoration diseases reflect diverse immunopathological mechanisms
by: Price, Patricia, et al.
Published: (2009)

Searching for an immunogenetic factor that will illuminate susceptibility to non-tuberculous mycobacterial disease
by: Affandi, J., et al.
Published: (2013)

The number and function of circulating dendritic cells may limit effector memory CD4+ T-cell responses in HIV patients responding to antiretroviral therapy
by: Fernandez, S., et al.
Published: (2008)

Susceptibility to non-tuberculous mycobacterial disease is influenced by rs1518111 in IL10
by: Halstrom, S., et al.
Published: (2017)

Characteristics of natural killer cells in Malaysian HIV patients presenting with immune restoration disease after ART
by: Tan, D., et al.
Published: (2010)

The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2011)

Is Pulmonary non-Tuberculous Mycobacterial Disease Linked with a High Burden of Latent Cytomegalovirus?
by: Amran, F., et al.
Published: (2016)

Antibody and B-cell responses may control circulating lipopolysaccharide in patients with HIV infection
by: Lim, A., et al.
Published: (2011)

Interferon-? and IL-5 production correlate directly in HIV patients Co-infected with mycobacterium tuberculosis with or without immune restoration disease
by: Oliver, B., et al.
Published: (2010)

Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2010)

Levels of anti-cytokine antibodies may be elevated in patients with pulmonary disease associated with non-tuberculous mycobacteria
by: Kim, K., et al.
Published: (2014)

The search for a genetic factor associating with immune restoration disease in HIV patients co-infected with Mycobacterium tuberculosis
by: Affandi, J., et al.
Published: (2013)

A haplotype spanning P2X7R, P2X4R and CAMKK2 may mark susceptibility to pulmonary non-tuberculous mycobacterial disease
by: Halstrom, S., et al.
Published: (2017)

Impaired function of regulatory T-cells in patients with chronic obstructive pulmonary disease (COPD)
by: Tan, D., et al.
Published: (2014)

The Use of Humoral Responses as a Marker of CMV Burden in HIV Patients on ART Requires Consideration of T-Cell Recovery and Persistent B-Cell Activation
by: Brunt, S., et al.
Published: (2014)

Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (TH1, TH2) to immune-mediated tumour cell death induced by NAC
by: Kaewkangsadan, Viriya, et al.
Published: (2016)

Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (TH1, TH2) to immune-mediated tumour cell death induced by NAC
by: Kaewkangsadan, Viriya, et al.
Published: (2018)

Defining the mechanisms of inflammation that underlie the pathogenesis of ovine footrot
by: Maboni, Grazieli
Published: (2017)

Immune reconstitution syndrome is not a single entity
by: Price, Patricia, et al.
Published: (2008)

Mechanisms regulating angiogenesis underlie seasonal control of pituitary function
by: Castle-Miller, Jennifer, et al.
Published: (2017)

Shared molecular genetic mechanisms underlie endometriosis and migraine comorbidity
by: Adewuyi, Emmanuel, et al.
Published: (2020)

Multivariate immunoprofiling of individuals prone to non-tuberculous mycobacterial infection reveals T cell exhaustion and dysfunction
by: Ratnatunga, C., et al.
Published: (2016)

Antibody and markers of T-cell activation illuminate the pathogenesis of HCV immune restoration disease in HIV/HCV co-infected patients commencing ART
by: Yunihastuti, E., et al.
Published: (2011)

Short communication: Plasma levels of vitamin D in HIV patients initiating antiretroviral therapy do not predict immune restoration disease associated with mycobacterium tuberculosis
by: Price, Patricia, et al.
Published: (2012)

Calcium–axonemal microtubuli interactions underlie mechanism(s) of primary cilia morphological changes
by: Buljan, V., et al.
Published: (2018)

Interaction of Pseudomonas aeruginosa biofilm with inflammatory cytokines and immune cells
by: Rahman, Tamanna
Published: (2016)

Role of interferon regulatory factor 5 (IRF5) in the regulation of t helper cytokines
by: Amar Singh, Ashwinder Kaur
Published: (2021)

Investigation of tnfr2 regulatory t cells and associated cytokines on the pathogenesis of nasopharyngeal carcinoma
by: Rahman, Engku Nur Syafirah Engku Abd
Published: (2023)

Increased CTLA-4+ T cells may contribute to impaired T helper type 1 immune responses in patients with chronic obstructive pulmonary disease
by: Tan, D., et al.
Published: (2017)

Plasma biomarkers in the prediction and diagnosis of tuberculosis-associated immune reconstitution inflammatory syndrome
by: French, M., et al.
Published: (2011)

Learning in imbalanced relational data
by: Ghanem, Amal, et al.
Published: (2008)

The Western Environment Reduces Innate Immune Cytokine Production in Chinese Immigrants.
by: Saiganesh, A., et al.
Published: (2017)

Reply to 'TLR-2 ligand lipomannan from Mycobacterium tuberculosis does not stimulate inflammatory cytokines in dendritic cells'
by: Tan, D., et al.
Published: (2012)

Nutritional and immune-regulatory approaches in abating bovine mastitis
by: Mohamed Mustapha, Noordin
Published: (2004)

Cannot write session to /tmp/vufind_sessions/sess_971eso78g2oienmhk4rfqn3fm5